Stocktoria
Drugs Made In America Acquisition II Corp. DMII
Nasdaq · XNAS · stock · Blank Checks · IPO 2025-09-25
Drugs Made In America Acquisition II Corp. financials (annual, from 10-K)
| Metric | FY2025 |
|---|---|
| Operating income | -$488,385 |
| Net income | $4.2M |
| Operating cash flow | -$1.0M |
| Cash & equivalents | $223 |
| Total assets | $505.0M |
| Total liabilities | $17.8M |
| Shareholders' equity | -$17.8M |
Source: SEC EDGAR filings · CIK 0002040475 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.